PSMD1 and COVID-19: However, already after the first vaccination dose, the geometric mean of anti-S1 IgG and anti-S1 total Ig antibodies of vaccinees exceeded those of convalescent-phase COVID-19 patients, 47 and 37 vs. 20 and 23, respectively (Fig. 1A, Table 1).